IL83586A - Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them - Google Patents
Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing themInfo
- Publication number
- IL83586A IL83586A IL83586A IL8358687A IL83586A IL 83586 A IL83586 A IL 83586A IL 83586 A IL83586 A IL 83586A IL 8358687 A IL8358687 A IL 8358687A IL 83586 A IL83586 A IL 83586A
- Authority
- IL
- Israel
- Prior art keywords
- hexahydroarylquinolizines
- spirocondensed
- peripheral
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1
- 125000004103 aminoalkyl group Chemical group 0.000 title 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 title 1
- 230000002093 peripheral effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 abstract 1
- 102000015006 alpha2-adrenergic receptor activity proteins Human genes 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90148586A | 1986-08-28 | 1986-08-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL83586A0 IL83586A0 (en) | 1988-01-31 |
| IL83586A true IL83586A (en) | 1991-12-15 |
Family
ID=25414273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL83586A IL83586A (en) | 1986-08-28 | 1987-08-19 | Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0259092B1 (pt) |
| JP (1) | JP2582799B2 (pt) |
| KR (1) | KR880002869A (pt) |
| AT (1) | ATE78482T1 (pt) |
| AU (1) | AU597412B2 (pt) |
| CA (1) | CA1288435C (pt) |
| DE (1) | DE3780542T2 (pt) |
| DK (1) | DK447387A (pt) |
| ES (1) | ES2044944T3 (pt) |
| GR (1) | GR3005537T3 (pt) |
| IL (1) | IL83586A (pt) |
| NZ (1) | NZ221485A (pt) |
| PT (1) | PT85593B (pt) |
| ZA (1) | ZA876400B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942235A (en) * | 1989-03-16 | 1990-07-17 | Merck & Co., Inc. | Process for certain (2R-trans)hexahydroaroquinolizines |
| US5229387A (en) * | 1991-09-20 | 1993-07-20 | Syntex (U.S.A.) Inc. | Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives |
| FR2744451B1 (fr) * | 1996-02-01 | 1998-04-24 | Pf Medicament | Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique |
| US6141745A (en) * | 1998-04-30 | 2000-10-31 | Advanced Micro Devices, Inc. | Functional bit identifying a prefix byte via a particular state regardless of type of instruction |
| FI126838B (en) | 2014-12-16 | 2017-06-15 | Vetcare Oy | Process for the preparation of spirocyclic substituted benzofuroquinolizines |
| FI131529B1 (en) | 2024-01-16 | 2025-06-11 | Vetcare Oy | Process for the racemization of benzofuroquinolizines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
| GB2106909B (en) * | 1981-10-07 | 1984-09-19 | Wyeth John & Brother Ltd | Benzoquinolizines |
| IE57014B1 (en) * | 1983-03-25 | 1992-03-11 | Wyeth John & Brother Ltd | Benzoquinolizines |
| ES8609323A1 (es) * | 1984-02-02 | 1986-07-16 | Merck & Co Inc | Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas. |
| NZ216283A (en) * | 1985-06-03 | 1989-10-27 | Merck & Co Inc | Hexahydro arylquinolizine derivatives and pharmaceutical compositions |
-
1987
- 1987-08-18 NZ NZ221485A patent/NZ221485A/en unknown
- 1987-08-19 IL IL83586A patent/IL83586A/xx not_active IP Right Cessation
- 1987-08-19 AU AU77205/87A patent/AU597412B2/en not_active Ceased
- 1987-08-26 DE DE8787307541T patent/DE3780542T2/de not_active Expired - Fee Related
- 1987-08-26 CA CA000545453A patent/CA1288435C/en not_active Expired - Lifetime
- 1987-08-26 EP EP87307541A patent/EP0259092B1/en not_active Expired - Lifetime
- 1987-08-26 AT AT87307541T patent/ATE78482T1/de active
- 1987-08-26 PT PT85593A patent/PT85593B/pt not_active IP Right Cessation
- 1987-08-26 ES ES87307541T patent/ES2044944T3/es not_active Expired - Lifetime
- 1987-08-27 DK DK447387A patent/DK447387A/da not_active Application Discontinuation
- 1987-08-27 ZA ZA876400A patent/ZA876400B/xx unknown
- 1987-08-28 KR KR870009444A patent/KR880002869A/ko not_active Withdrawn
- 1987-08-28 JP JP62214979A patent/JP2582799B2/ja not_active Expired - Lifetime
-
1992
- 1992-08-27 GR GR920401865T patent/GR3005537T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE78482T1 (de) | 1992-08-15 |
| IL83586A0 (en) | 1988-01-31 |
| ES2044944T3 (es) | 1994-01-16 |
| KR880002869A (ko) | 1988-05-12 |
| DE3780542T2 (de) | 1993-01-07 |
| ZA876400B (en) | 1988-02-25 |
| EP0259092B1 (en) | 1992-07-22 |
| AU7720587A (en) | 1988-03-03 |
| CA1288435C (en) | 1991-09-03 |
| DK447387A (da) | 1988-02-29 |
| AU597412B2 (en) | 1990-05-31 |
| JPS63139183A (ja) | 1988-06-10 |
| DE3780542D1 (en) | 1992-08-27 |
| NZ221485A (en) | 1991-04-26 |
| GR3005537T3 (pt) | 1993-06-07 |
| JP2582799B2 (ja) | 1997-02-19 |
| DK447387D0 (da) | 1987-08-27 |
| PT85593A (en) | 1987-09-01 |
| EP0259092A1 (en) | 1988-03-09 |
| PT85593B (pt) | 1990-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94040864A (ru) | Конденсированные индольные производные, их получение, фармацевтическая композиция | |
| KR890002030A (ko) | 메데토 미딘의 d 및 1 에난티오머, 그 분리 방법 및 이를 포함하는 제약학적 조성물 | |
| DE3779500D1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
| HU9203383D0 (en) | 2-amino-methyl-chromane derivatives and method for producing said compounds and pharmaceutical preparatives containing them | |
| IL104006A0 (en) | Azaheterocyclylmethyl-chromans,their preparation and pharmaceutical compositions containing them | |
| FI961809A0 (fi) | Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit | |
| RU93004793A (ru) | Производные хиназолина, способ их получения, фармацевтическая композиция на их основе | |
| PL330207A1 (en) | Aryl-substituted cyclic amines as selective ligands of d 3 dopamine | |
| TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
| FR2531950B1 (fr) | Derives d'amides d'acide o-amines, leur preparation, leur utilisation dans le traitement des affections du systeme nerveux central et des troubles cardiovasculaires, et compositions les contenant | |
| IL83586A (en) | Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them | |
| EP0554313A4 (en) | Disubstituted aryl compounds exhibiting selective leukotriene b 4? antagonist activity | |
| GB8807922D0 (en) | Isoquinoline compound & process for preparation thereof | |
| IL104005A0 (en) | Piperidylmethyl-substituted chroman derivatives,their preparation and pharmaceutical compositions containing them | |
| IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
| DK526087A (da) | Antikonvulsive aminosyrederivater | |
| ES557149A0 (es) | Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida. | |
| IT1209276B (it) | Composizione farmaceutica per la somministrazione orale del metilestere dell'acido 13a-etil-2,3,5,6,12,13,13a,13b-ottaidro-12-idrossi1h-indolo-[3,2,1-de] pirido [3,2,1-ij] [1,5] naftiridina -12-carbossilico | |
| IT1198263B (it) | Esteri dell'azoniaspironortropanolo,procedimento per la loro preparazione,mezzi farmaceutici che li contengono e impiego di esteri dell'azoniaspironortropanolo come spasmolitico,asmaterapeutico e broncolitico | |
| FI871479A0 (fi) | Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi | |
| MA19881A1 (fr) | Procede de preparation de derives de spiro (2h-1,4-benzodioxepine-3 (5h) 4'-piperidine et -3'-pyrrolidine). | |
| DK0950053T3 (da) | Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater | |
| EP0202986A3 (en) | Use of "naftidrofuryl" in the treatment of neuropathies | |
| RU93029617A (ru) | Имидазопиридины, способ их получения, фармацевтическая композиция и способ ее получения | |
| IE802600L (en) | Indole derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |